Life through discovery
Servier UK - Dr Jack Servier

Research and Development

“A Group that succeeds in research has every chance of succeeding in the world.  Research is our mission, it is the foundation of the pharmaceutical industry, and it is in that area that we must succeed.”
Dr Jacques Servier

Key facts about Research & Development

  1. The cost of developing a new medicine is about £550 million, 60% of which is spent in clinical trials
  2. The full drug development process takes 10-12 years
  3. Only one or two compounds in 10,000 tested are eventually authorised for use in patients
  4. A potential new medicine may be rejected at any stage of the development process on safety, efficacy or quality grounds

Servier regularly invests more than 25% of its annual turnover in research and development, which is significantly higher than the industry average of 17%. More than 2,600 of a total 20,000 employees across the world are dedicated to Research and Development.

Servier’s Research and Development pipeline is extremely healthy, having the potential to submit several true innovations for licence during the next 10 years.

As a priority, Servier invests in therapeutic areas where there is a medical need.  From a product portfolio focused on Cardiovascular disease, Diabetes and Osteoporosis, Servier plans to develop new and existing products by 2014 for Type 2 diabetes, hypertension, heart failure, prevention of cardiovascular events, depression, mild cognitive impairment, oncology and osteoarthritis. Over 30 drugs are currently in development.

In the UK there are two research and development divisions:

  1. The International Centre for Therapeutic Research
  2. The Centre for Biopharmacy Research

 

 

© 2007 LES LABORATOIRES SERVIER, an incorporated company of SERVIER. All Rights Reserved - Terms of Use
SERVIER does not sell its products over the Internet - More information
Last Updated 04/09/2008 14:07:00
Best viewed in Internet Explorer 6.0 or later, at 1024x768 resolution.